1. Home
  2. Analysis
  3. Acyclovir-sodium
  4. Valacyclovir

Acyclovir sodium and Valacyclovir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Acyclovir sodium and Valacyclovir. Common interactions include rhinitis among females and neurotoxicity among males.

The phase IV clinical study analyzes what interactions people who take Acyclovir sodium and Valacyclovir have. It is created by eHealthMe based on reports of 27 people who take Acyclovir sodium and Valacyclovir from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

27 people who take Acyclovir sodium and Valacyclovir together, and have interactions are studied.

What is Acyclovir sodium?

Acyclovir sodium has active ingredients of acyclovir sodium. eHealthMe is studying from 1,439 Acyclovir sodium users for its effectiveness, alternative drugs and more.

What is Valacyclovir?

Valacyclovir has active ingredients of valacyclovir hydrochloride. It is often used in herpes zoster. eHealthMe is studying from 28,892 Valacyclovir users for its effectiveness, alternative drugs and more.

Number of Acyclovir sodium and Valacyclovir reports submitted per year:

Acyclovir sodium and Valacyclovir drug interactions.

Common Acyclovir Sodium and Valacyclovir drug interactions by gender *:

female:

  1. Rhinitis
  2. Throat irritation
  3. Tooth abscess
  4. Tooth extraction
  5. Vision blurred
  6. Cytomegalovirus infection
  7. Cytomegalovirus viraemia
  8. Encephalitis cytomegalovirus
  9. Pathogen resistance
  10. Alanine aminotransferase increased

male:

  1. Neurotoxicity
  2. Drug ineffective
  3. Toxic epidermal necrolysis
  4. General physical health deterioration
  5. Necrotising retinitis
  6. Oesophagitis
  7. Renal failure
  8. Renal failure acute
  9. Retinal detachment
  10. Seizure

Common Acyclovir Sodium and Valacyclovir drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

  1. General physical health deterioration
  2. Oesophagitis
  3. Thrombocytopenia

20-29:

  1. Thrombocytopenia
  2. Thrombotic microangiopathy
  3. Tubulointerstitial nephritis
  4. Venoocclusive liver disease
  5. Acute graft versus host disease
  6. Acute graft versus host disease in liver
  7. Acute graft versus host disease in skin
  8. Altered state of consciousness
  9. Anaphylactoid reaction
  10. Blood lactate dehydrogenase increased

30-39:

n/a

40-49:

  1. Drug ineffective
  2. Liver disorder
  3. White blood cell count decreased
  4. Metabolic acidosis
  5. Neutropenia
  6. Pyrexia
  7. Respiratory failure
  8. Septic shock
  9. Stevens-johnson syndrome
  10. Toxic epidermal necrolysis

50-59:

  1. Neurotoxicity
  2. Alanine aminotransferase increased
  3. Atrial fibrillation
  4. Cardiac failure congestive
  5. Pneumonia
  6. Respiratory failure
  7. Seizure
  8. Status epilepticus

60+:

  1. Cytomegalovirus infection
  2. Cytomegalovirus viraemia
  3. Bone lesion
  4. Breast cancer metastatic
  5. Bronchopulmonary aspergillosis
  6. Chronic obstructive pulmonary disease
  7. Chronic sinusitis
  8. Constipation
  9. Death
  10. Decreased interest

Common conditions people have *:

  1. Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 14.81%
  2. Stress And Anxiety: 3 people, 11.11%
  3. Pain: 3 people, 11.11%
  4. Insomnia (sleeplessness): 3 people, 11.11%
  5. Hiv Infection: 3 people, 11.11%
  6. Bone Marrow Conditioning Regimen: 2 people, 7.41%
  7. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 7.41%
  8. Cough: 2 people, 7.41%
  9. Depression: 2 people, 7.41%
  10. Diabetes: 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Acyclovir sodium and Valacyclovir?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Acyclovir sodium and Valacyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Acyclovir sodium side effects:

Browse all side effects of Acyclovir sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Valacyclovir side effects:

Browse all side effects of Valacyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Acyclovir sodium interactions:

Browse all interactions between Acyclovir sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Valacyclovir interactions:

Browse all interactions between Valacyclovir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on acyclovir sodium and valacyclovir hydrochloride (the active ingredients of Acyclovir sodium and Valacyclovir, respectively), and Acyclovir sodium and Valacyclovir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Acyclovir sodium and Valacyclovir.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.